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Abstract 
         The folate receptor is overexpressed on the surface of numerous cancer cell types including 
those of the breast, lung, kidney, ovary, and brain [1, 2].  Recent interest has exploded in the use 
of folate to deliver payloads and imaging agents to folate receptor positive cancer cells based on 
several positive clinical trials including phase III trials of EC-145, which is poised to become the 
first folate targeted, FDA approved drug [3].  Given the success of EC-145 and numerous other 
agents in the pharmaceutical pipeline, there remains a great interest in the exploitation of this 
technology in the delivery of nanoscale agents to folate receptor positive cancer cells [3].  In this 
review I will examine the current status and role of folate targeted nanoconjugates for both 
diagnostic imaging and therapy.  
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Introduction 
           Cancer affects the lives of many people in more ways than one and is a leading cause of 
death in today’s society.  Radiation of the patient undergoing treatment for cancer with the use of 
certain chemotherapies usually results in the destruction of healthy tissue that leaves the patient 
with unwanted and harmful side effects.  In the past two decades scientific research has come up 
with many innovative procedures in detecting cancer and treating different types of cancer 
without the unwanted side effects.  One major breakthrough in cancer research has been the 
discovery of the tumor associated antigen known as the folate receptor (FR) which has a high 
binding affinity for the vitamin folic acid.  Researchers have discovered ways of conjugating 
nanoparticles such as BSANPs (bovine serum albumin nanoparticles), mesoporous silica, gold, 
metallic and quantum dots to folic acid in an effort to selectively target cancerous cells that result 
in cellular penetration causing apoptosis of the cell tissue that is specifically infected without the 
harmful side effects that follow conventional treatments.  Many nanoparticle conjugates that 
have been used for selective targeting of cancers show promising results with the large payloads 
of the drug entering the cell into the cytoplasm via attachment the nanoparticle and FA causing 
its damage to the cell thus preventing the tumor cells from metastasizing. The greatest benefits of 
using folate conjugated nanoparticles for cell targeting is the reduction in side effects as well as 
the increase in the potency of the drug due to the large payload being taken into the cell through 
endocytosis.  The focus of this paper is mainly on the advancements of folate nanoparticle 
conjugates that have been researched and used for  bio-imaging in order to determine where 
exactly the cancer is located and intracellular delivery of the drug causing the destruction of 
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cancerous cells by targeting the folate receptor which is normally found in large concentrations 
on cancerous tissue.  
 
Background 
         Folic acid or pteryol-L-glutamate belongs to the vitamin B family and is a necessary 
compound or molecule used in many reactions by the body for red blood cell proliferation and is 
involved in many reactions for DNA synthesis and repair (See Figure 1.) for chemical strucutre.  
In the past decade or so researchers have indicated that there is an increased expression of the 
folate receptor which has been identified as a tumor marker on many cancerous tissues such as 
human lung, intestinal tract, kidney, ovary, breast, brain, colon, and endometrium [1, 4].  The 
folate receptor is a glycopolypepetide with a high binding affinity KD<10-9 M for folic acid.  
Human folate receptor falls into a family of genes that is categorized by three types –α, β, and –γ 
each with its own specific tissue distribution and different binding affinities for folic acid [2, 5].  
Folate receptor alpha is the most widely researched and over expressed form of the three and due 
to the increased expression of FRα in epithelial tumor cells it has been considered as a good 
targeting marker for the use with new selective anti-cancer drugs [6, 7].  The FRα is also 
expressed on normal epithelial tissue one major concern is the destruction of healthy tissue 
throughout the body and surrounding areas where the tumors are located but since the FRα has a 
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restrictive anatomic distribution on the luminal surfaces of healthy epithelial tissue this spares 
these tissues from FR targeted agents [6].  When designing folate nano-conjugates environmental 
pH should be considered. Once folic acid forms a complex with the folate receptor the complex 
is endocytosed with a change in pH environments, acidic environments that can modify the 
nano-conjugate properties resulting in destruction, or formation of different complex and early 
release of the payload as a result of the nano-conjugates coming together.  Utilizing 
nanoparticles conjugated to folate for targeting of the folate receptor should tolerate a wide pH 
range in order to efficiently target the folate receptor and allow for a more controlled release of 
the payload once endocytosed.  
        When using folate as a carrier a major concern is the rapid expulsion or release of the 
nanoparticles through the reticuloendothelial system which is also over expressed with FRα. 
Pegylation which is the attachment of nanoparticles to folic acid by polymeric chains allows for 
longer systematic circulation thus larger concentrations of nanoparticles are able to reach their 
target allowing for a higher uptake of drugs or other agents into the cells [8].  The compound 
folic acid is a water soluble compound and has its advantages when used as a targeting agent for 
tumor cells it has a low molecular weight of 441 Da, it has high affinity for the folate receptor 
and inexpensive, stable, and non-immunogenic compared with proteins such as monoclonal 
antibodies [9].  Nanoparticles have been of considerable interest in targeting cancerous cells 
because of the reduced toxicities as well as the enhanced therapeutic effects.  Nanoparticles show 
sufficient physical and biological stability that facilitates entrapment of a large payload and drug 
release they have good tolerability of components, as well as a simple conjugation process with 
folic acid [9]. The development and use of nanoparticles conjugated to folic acid has tremendous 
advantages in fighting cancer. Metallic nanoparticles are used in bio-imaging due to their 
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controllable light emission which allows for detection and location of the tumor cells, 
photodynamic therapy allowing for the destruction of tumor cells in specific regions sparing the 
surrounding healthy cells [8].    
Pegylated nanoparticles for the enehancement of circulation and targeting of FR+ cancer 
cells.  
        One problem with using conventional anticancer agents is not only do they target the 
cancerous cells but they also target healthy cells and are easily excreted through the body and 
systematic circulation. First the toxic effects of the drugs cause unnecessary cell death and 
second rapid excretion of the drug and the nanoparticle by the body will reduce its targeting 
efficiency [10, 11, 12].  One major goal is to increase systematic circulation of the drug in order 
to deliver a large payload as well as increase the binding efficacy of the nanoconjugate without 
damaging healthy tissue.  Prior research has determined that the concentrations of the FR are 
100-300 times higher on cancerous cells compared to healthy cells it has also been concluded 
that as the stage of the cancer increases so does the FR density this benefits the use of 
nanoparticles conjugated to folic acid allowing for a higher efficiency of binding to the FR and 
delivery of a large payload or drug to the tumor cells [10, 11].  Targeting of tumors occurs 
through the EPR method the enhanced permeability and retention effect which is based on the 
fact that as tumor cells become larger they stimulate the production of new vessels that result in 
leaky fenestrations that allow passage of macromolecules and NPs into the tumor cells [10, 14]  
One major drawback of the FR is that high concentrations naturally occur in the proximal tubules 
of the kidney which allows for excretion of folic acid as well the clearance of the nanoparticles 
and necessary drugs needed to target the tumor cells.  The development of PEG poly(ethyelene 
glycol) backbones has been shown to reduce the clearance of nanoparticles by the 
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reticuloendothelial system in order to increase the targeting efficiency to the FR by increasing 
the half-life of the nano-particles carrying the drug or payload in the blood stream [10, 11, 12].  
The use of PEG spacers tethered to  liposomes and folic acid for targeting of FR+ cells were 
found to enter the target cells at much higher concentrations then the control groups with a cell 
death count 85 times greater than the controls [1].   PEG backbones containing varying numbers 
of –NH2 groups (Au-PAM4-20K-FA) PEG-tetra-amine molecular weight 20000, (PAM2-2k), 
(PAM2-10k), PEG-diamine with molecular weights 2000 and 10000 respectively and (PSH2-
2K) PEG-dithiol with moleculare weight 2000 were used to determine the targeting efficacy of 
folate decorated nanoparticles to the FR+ cells [12]. (See Figure 2)  In this study Battacharya et 
el. determined that AuNPs had a much higher binding capacity to the sulfhydral groups on the 
PEG-dithiol with PEG-tetra-amine having the second highest binding capacity to AuNPs. It was 
also determined that PAM4-20K-AuNPs had a much higher binding efficiency to Folate then 
Au-PSH2-2K [12].  Due to its higher binding efficiency to folate Au-PAM4-20K was used for 
testing on OV-167 and OPM-1 ovarian cancer cells which show the highest concentration of 
folate receptor compared to other cell lines such as OVCAR-5, and RPMI cells.  After a 1 hr 
treatment of Au-PAM4-20K to OV-167 TEM images show a more intense color compared to 
OVCAR-5 which have lower FR expression. The images clearly indicate that nanoparticle 
internalization is greater in cells lines that have higher concentrations of FR due to the attraction 
of folate to the FR and the pegylation of the nanoconjugate.  The uptake of Au-PAM4-20k was 
also higher and showed a more intense color in OPM-1 cells compared to cells with lower FR 
concentration (See Figure 3) [12].  Altering the attachment of folate to gold nanoconjugates by 
using different PEG structures Battacharya et el. showed that amine containing PEG structures 
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are the choice when tethering folic acid to nano-conjugates and that there is an increase in the 
uptake of gold nanoparticles by FR+ cells..      
              Experiments to see which nano-conjugate had a higher cellular internalization were 
implemented using mPEG–thioacetamide (mPEG-2000T):AuNPs, and FA-mPEG-thioacetamide 
(mPEG-1500T):AuNPs which were then analyzed by transmission electron microscopy that 
indicate the folate coated polyethylene glycol nanoparticles had a higher internalization and 
selective uptake by KB cells then the mPEG- thioacetamide gold nanoparticles alone (See figure 
4) [11].  The use of PEG backbones is an excellent way of increasing the circulation of 
nanoparticles in vitro and in vivo resulting in a higher targeting efficiency as well as the delivery 
of large payloads to FR+ cells. 
 
                   Figure 2. Chemical structure of different PEG backbones [12] 
 
 
  
12 
 
Figure 3. TEM images of OPM-1 cell treated for 1 hr with AuPAM4-20k-FA.  
A, Internalization of AuPAM4-20k-FA cells. B, C, Images of A at higher magnification. The 
micrographs with arrows show the internalization of gold nanoconjugates and their localization 
in early and late endosomes.  D, Rpresentative picture of the intracellular nanoconjugate uptake 
by OPM-1 cells during a five minute treatment [12]. 
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Figure 4.  Representation of the PEG-Modified AuNP used and their exposure to FR+ and FR- 
cells [11]. 
 
 
Folate Nanoparticle Conjugates for intratcellular tracking of payloads and in Imaging of 
Cancer cells 
       Nanoparticles conjugated with folic acid are not only beneficial in delivering large payloads 
of medicine to the FR+ cells for destruction.   Nanoparticles are very useful in MRI magnetic 
resonance imaging for detecting where the cancerous tissue is, as well as a tracking device 
allowing for real time visualization in where the medicine is being distributed.  Folate 
nanoparticle conjugates can be tethered to certain fluorescent probes in order to track the bio 
distribution of the payloads through bio imaging.  One of the first bio-imaging agents to be 
conjugated with folic acid for imaging of cancer cells is ¹¹¹In.  The light emitting agent was 
preferred because of its short half-life and rapid excretion. Imaging agents that remain in Fr- 
cells will tend to contribute to nonspecific background and the therapeutic agents will usually 
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result in off target toxicity [1].  The use of ¹¹¹In-DTPA-FA clearly shows a more intense 
luminescence throughout the patient that is malignant indicating that ¹¹¹In-DTPA-FA has been 
endocytosed by the cancerous cells resulting in visualization of the cancer for site specific 
targeting [1, 3].   
Mesoporous Silica Nanoparticles 
      There are a number of Multifunctional nanoparticles which can be used to simultaneously 
deliver large payloads of medicine as well as give real time visualization in the delivery of the  
nano-conjugates.  Mesoporous silica nanoparticles are an excellent source for conjugation to 
folic acid in which fluorophores such as FITC can be thethered to and used in the imaging of 
cancer. Silica already exists in the human body as silicone dioxide (28).   Silica conjugated by a 
PEG spacer to folic acid and tethered to FITC flourosceine isothiocyanate, NPs(FITC)-PEG-
Folate are used to deliver as well as track the payload by fluorescence. In order to prove that 
PEG- Folate was conjugated to The Nps(FITC) FT-IR spectral analysis was done on NPs(FITC)-
PEG-Folate and NPs(FITC).  As you can see from (figure 5) in the FT-IR spectra there are two 
distinct peaks at 1500 cm-1 and 1657 cm-1 and corresponds to the benzene of the folate and the 
NH2 of the nanoparticle resulting in the successful formation of the nano-conjugate [13].    
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Figure 5. FT-IR spectra of NPs(FTIC)-PEG-Folate and NPs(FITC) [13]. 
 
(Figure 5.1) shows a diagram for the synthesis of NPs(FITC)-PEG-Folate.   Observation of  KB 
cells under an inverted confocal microscope clearly indicates that NPs(FITC)-PEG-Folate have 
higher internalization compared to NPs(FITC) and is indicated by the intense fluorescence for 
KB cells that are FR+ and little or no fluorescence by those cells that are FR-. (See figure 5.2) 
The use of the NPs (FITC) folate nano-conjugates with FR+ KB cells in this study researchers 
were able to show the direct targeting and tracking of the nano-conjugates by fluorescence. [13].   
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  Figure 5.1 
Preperation of NPs(FITC)-PEG-Folate. The maleimde end of the maleimide-FITC reacts with 
thiol groups of 3-mercaptopropyltrimethoxysilane forming thioester linkages.  Folate is then 
activated using ethy(diethylaminopropyl) carbodiimide/N-hydroxysuccinimide and reacted with 
NH2-PEG-maleimide to form the reactive intermediate maleimide-PEG-Folate which then reacts 
with NPs(FITC) to produce NPs(FITC)-PEG-Folate [13].  
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      Figure 5.2  FR+ KB cells incubated in Non targeted NPs(FITC) nanoparticles top panel in 
comparison with targeted NPs(FITC)-PEG-Folate at 37 degrees Celsius for 6 hours [13]. 
 
   
Magnetic Nanoparticles             
        Supraparamagnetic iron oxide nanoparticles such as magnetite Fe3O4 are also 
multifunctional nanoparticles very useful in magnetic resonance imaging due their magnetic 
properties.  What makes Magnetic nanoparticles so useful for MRI is that they can be controlled 
by their shape, size, and composition of their magnetic core [14].   Magnetic nanoparticles that 
are not modified are very stable at low and high pH.  Even though (supraparmagnetic iron oxide 
nanoparticles) or SPIONs are very stable at different pH values iron oxide agglomeration can 
occur in vivo resulting in inefficient nanoparticle distribution. To protect the uniformity and 
stability of the SPIONs as well as provide a multitude of arms for conjugation to medicines and 
their targeting receptors they can be coated with different polymers such as PEG, dextran, or 
phospholipids in situ.  SPIONs that are coated with PEG are very useful for cell targeting in that 
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they are able to bypass the reticuloendothelial system resulting in higher concentrations of NPs 
to their target.   Supraparamagnetic iron oxide nanoparticles can be conjugated with linker agents 
that contain a sulfhydral group that binds the amino group that is on the SPION allowing for 
control over the bound ligands.  Hogman et el used SPIONs and linked them with transferrin 
protein by using pyridyl disulfide (PD) and was able to show that there was a 4 fold increase in 
the binding of Tf molecules for each individual SPION as well as a 10 fold improvement in 
cellular uptake allowing for a more sensitive SPION for imaging [14]  
          In another study magnetic nanoparticles are conjugated to folic acid and coupled with 
methacrylamido to formulate MA-FA-Fe3O4 nano-conjugates which were used to determine the 
cellular internalization of the nanoparticles as well as to target the cancer cell in order to cause 
cell death by apoptosis [15].  This study first revealed that a 4.5µg/ml concentration of the folic 
acid conjugate is all that is required to cause cell apoptosis in 5RP7 cancer cells which have high 
concentrations of the FR compared to NIH/3T3 cells.   TEM images of the magnetic 
nanoparticles can be seen in (figures 6) the TEM images of MA-FA-Fe3O4 indicate that first 
cellular internalization of the nano-conjugate has occurred and second the nanoparticles are 
imaged [15]. The TEM images in (Figure 6.1) of normal cells incubated with MA-FA-Fe3O4 
shows that internalization of the nano-conjugate has occurred and indicates high cell viability 
after 24 and 48 hour treatment of the MA-FA-Fe3O4 with no internal damage due to the cells 
remaining intact [15].  Comparing the TEM images of the 5RP7 cells incubated with MA-FA-
Fe3O4 to those of the NIH/3T3 cells it’s a clear observation (See figures 6.2) that internal 
cellular damage has occurred leading to apoptosis of the folate receptor positive cells [15].  The 
increased cell death of the 5RP7 cells was most likely due to the increased uptake of the 
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magnetic nano-particle conjugates resulting from the formation and endocytosis of the folic 
acid/FR complex in which NIH3T3 cells are deficient resulting in the higher cell viability.   
Figure 6  TEM images showing of Fe3O4 nanoparticles [15]. 
 
 
 
 
Figure 6.1 TEM images of NIH/3T3 cells treated with 4.5µg/ml of nano-conjugate (a) after 24 
hr treatment and (b) after 48 hr treatment [15] 
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Figures 6.2   TEM images of 5RP7 cells indicating apoptosis after e. 24 hr treatment of 4.5µg/ml 
of nano-conjugate and f. 48 hr treatment leading to cell death [15]. 
 
          
 
 
Quantum Dots 
      Quantum dots which are semiconductor nanocrystals are a good source for use in bio-
imaging of cancer.  Quantum dots such as CdSe, CdS, ZnS, PbS, and PSe are very beneficial in 
that their absorption properties can be tuned from visible to near infrared region which allows 
them to emit a multitude of colors with very intense signals depending on their size and the 
wavelength of the excitation source. One of the drawbacks to quantum dots is their long lived 
circulation in the blood stream which increases their toxicity level [16, 17, 18]. There has been 
an effort to reduce the toxicity of quantum dots by tethering them to folic acid in conjugation 
with silicon a non-toxic agent to form FA-Si-QD (See Figure 7).  The formation of Si-QD 
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nanoparticles tends to have lower toxicity levels compared to conventional QDs and results in 
quick expulsion through the renal system as silicic acid [18].  (See Figure 7.1).  Folate receptor 
positive cells that were incubated with FA-Si-QDs and then pre-saturated with folic acid show 
very low luminescence in Panc-1 cells. Panc-1 cells that are incubated with FA-Si-QDs without 
any pre-saturation of folic acid result in higher cellular uptake and is clearly visualized by false 
color confocal images. Si-QDs are good agents for conjugation to folic acid for further research 
allowing for real time visualization [18].  (See Figure 7.2)  Cytotoxicity assays carried out on 
human pancreatic cells using hydrogen terminated Silicone quantum dots and cysteine capped 
CdTe QDs indicates that there is a higher cell viability of Panc-1 cells when exposed to Si QDs 
compared to the conventional QDs such as CdTe [18]. 
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 Figure 7   a. hydrosilylation with undecylenic acid; b. EDC coupling to the o-acylisurea ester; c. 
formation of NHS-ester; d. bioconjugation [18]. 
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Figure 7.1  
b. False color confocal images of Panc-1 cells incubated with FA-Si-QDs after saturation with 
excess folic acid which is preventing the internalization nanoparticles conjugates. c. Panc-1 
cancer cells incubated with FA-Si-QD alone. The bright green fluorescence clearly indicates 
cellular uptake of the nanoparticles [18]. 
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 Figure 7.2   Comparison of cytotoxicity assays of Si-QDs and CdTe quantum dots in µg/ml it 
can be seen that the at high concentration range of Si-QDs cell viability is higher compared to 
the cell viability cells treated with CdTe quantum dots [18]. 
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Gold Nanoparticles 
       Gold has had a place in the field of medicine ever since ancient times and has been known to 
be used by the Chinese for its therapeutic purposes. Red colloidal gold is used by the elderly in 
India as an ayurvedic medicine for revitalization and rejuvenation.  Gold because of its non-toxic 
properties has worked its way into western medicine for the treatment of certain disorders such 
as epilepsy and other nervous disorders [12, 16].   Gold is the most stable of all the metals and 
what makes it so attractive in nano medicine is its biocompatibility, its ease of use when 
designing new nano-conjugates, and SPR (surface plasmon resonance) bands that allows for easy 
characterization [11, 16].  Gold nanoparticles exhibit scattering at two wavelengths which are 
tunable in the visible as well as the near IR region and is due to their SPR.  Gold nanoshells 
made from a silica core with a coating of gold nanoparticles showed resonance at 700-750 nm 
for a 20 nm gold nanoshell with a 60 nm silica core, the same size silica core with a 5 nm gold 
nanoshell resonated between 1000 and 1050 nm [16, 17].  Gold is very useful in the delivery of 
nano-medicines because its stability in vitro and wide pH range (2-12) that it can take on once 
endocytosed by the cell [11].   
         The absorbance of light in the visible region by the gold nanoparticles is what makes it so 
useful in the thermal destruction of cancerous cells in a process called nanophotothermolysis. In 
the process of photothermolysis AuNPs absorb light and tend to build up heat within a 
picosecond time scale causing destruction of local cells that are targeted [19].  Zharov et el. 
determined that a 30 nm AuNP irradiated at a wavelength of 532 nm with a fluence equal to 0.5 
J/cm² and after a 20 ns pulse could produce temperatures up to 2500 K which can be used to 
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destroy cancerous cells [19].  In two separate studies Mansoori conjugated (See Fiure 8) (4 atp), 
4-aminothiophenol with AuNPs via thiol group to form 4atp-AuNPs which was then conjugated 
to folic acid by amine binding.  Using the AuNP nano-conjugate that were designed Mansoori 
was able to target HeLa cancer cells that are FR+ as well as cause thermal ablation of the cells by 
nanophotothermolysis and then compared data of the cellular uptake and cell death in MCF7 
cells that are FR- determining that the Folate-4atp-AuNP is a very suitable agent for selective 
targeting of cancer.  
Figure 8.  Diagram for the reaction of 4-aminothiophenol to AuNps and then folic acid [20]. 
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       To test for the cytotoxicity of the AuNP nano-conjugate on the two different cell lines such 
as FR- MCF7 cells and FR+ HeLa cells Mansoori et el incubated the cells with Folate-4atp-
AuNP for 1, 2 and 4 hour periods and observed that there was no cell lethality for either MCF7 
or HeLa cells as can be seen from (figure 8.1) [19, 20].  
Figure 8.1 Cytotoxicity assay of AuNP nano-conjugate on HeLa and MCF7 cell for 1 and 2 hour 
incubation periods [20]. 
  
     Folate receptor negative MCF7 cells and folate receptor positive HeLa cells were subjected to 
an Intense Pulse light (IPL) to determine the cell lethality when exposed to varying pulses of 
light with treatment parameters that consisted of 15 J/cm² for energy fluency, with a cut off filter 
of 560 nm and a pulse duration of 3 milliseconds. Both cell lines were exposed to 10, 15, 20, 30, 
and 40 pulses [19, 20].  From observation of the data in figure 8.2 it can be concluded that there 
was no cell lethality and that IPL does not cause destruction of either cell lines when exposed to 
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20 pulses and the correct specifications resulting in a suitable number of pulses to use when 
irradiating the cells containing the entrapped cargo. Cell viability of both HeLa , and MCF7 cells 
did drop but only after exposure to pulses of 30 and 40 [19,20]. 
Figure 8.2 Percent survival of HeLa and MCF7 cells after exposure to varying numbers of IPL 
with an operating mode: 8 mm x 15 mm; fluency 15 J/cm²; filter wavelength 560 nm; pulse 
duration of 3 milliseconds [19]. 
 
        Knowing that Folate-4atp-AuNP indicated no cytotoxic effects on HeLa and MCF7 cells 
and with the correct number of pulses for IPL Mansoori was able to show that there is a 
significant difference in cell viability between FR+ HeLa cells and FR- MCF7 cells that are 
incubated with Folate-4atp-AuNp and exposed to irradiation as observed from (figure 8.3).  
Each cell line was incubated with a specific concentration of the nano-conjugate then irradiated 
in 3 millisecond increments to observe the effects of photothermolysis on FR+ cells as well as 
FR- cells.  It’s obvious that exposure to different concentrations of nano-conjugates and (IPL) 
Intense pulsed light to FR- MCF7 cells shows no cell lethality where the FR+ HeLa cells do 
indicate cell death.  The fastest increase in cell destruction occurred when 5 µg/ml of the nano-
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conjugate was added and the incubation time was changed from 1 hour incubation to 2 hour 
incubation which had only 29 % cell survival where the incubation period for 1 hour showed 77 
% cell survival [19, 20].  Using the  AuNP nano-conjugate tethered to 4-aminthiophenol and 
folate Mansoori was able to show the cellular uptake of the nano-conjugate by FR+ HeLa cells, 
that no toxicity occurred when the cells where incubated with the nano-conjugate alone as well 
as the destruction of FR+ HeLa cells.  
Figure 8.3 Percent survival of Hela and MCF7 cells after 1, 2, and 4 hour exposure to nano-
conjugate and radiated with IPL [20] 
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    Liposomes   
      Liposomes which are mainly composed of phospholipid bilayers are very useful in the 
delivery of a medicines, enzymes, coenzymes, genetic material and are able to entrap a high 
concentration of payloads to the site of infection either by passive, or active targeting [21].  As 
the nature and function of liposomes was further understood researchers were able to attach other 
functional molecules such as PEG to their surface in order to increase longer circulation in vivo 
by preventing the non-specific opsonisation by phagocytes.  Liposomes have the capability of 
encasing hydrophilic and hydrophobic molecules and at the same time maintain all cellular 
activities such as accumulation at the target tissue due to long systematic circulation and 
controlled drug release [22, 23].  Liposomes are able to infiltrate the tumor cells mainly by 
passive targeting by way of the enhanced permeability and retention effect through the leaky 
vasculature associated with the tumor.  Liposome infiltration into the tumor cells can be 
increased by conjugation to folic acid resulting in an increased efficiency and delivery of the 
payload within the liposome.  With the advancements and technology in the treatment of cancer 
liposomes have been tethered to Gadolonium which allows for MRI imaging of tumor cells.  
Liposomes have also been used for entrapping and delivery of ZnTPP (zinc-
tetraphyenylporphryn) a photosensitizers in an effort to minimize the unwanted side effects due 
to normal tissue damage as well as to destroy the tumor cells with photodynamic therapy.  
             In a 2009 study which researched the uptake and MRI imaging of cancer cells used (See 
Figure 9) targeted liposomes consisting of Gd.DOTA.DSA/DOPC/Cholesterol/DSPE-
PEG2000/DSPE-PEG(2000)Folate/DOPE-Rhodaamine 30/32/30/4/3/10 mol % , and non-
targeted liposome formulation which consisted of Gd.DOTA.DSA/DOPC/Cholesterol/DSPE-
PEG2000/DOPE-Rhodamine with a molar ratio of 30/32/30/7/1 mol % (50).  IGROV-1 cancer 
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cells having an overexpression of folate receptor on the cell surface were incubated with targeted 
and non-targeted liposomes and then compared post incubation.  To test for the internalization of 
157Gd by IGROV-1 cells ICP-AES measurements were conducted.  (See Figure 9.1) ICP-AES 
analysis of IGROV-1 cells incubated for 5 hours with non-targeted liposomes and 0.03 mol % 
folate liposomes shows very low concentrations in ppm of Gadolonium-157 being internalized 
by the cells.  Observing IGROV-1 cells that were incubated with targeted liposomes containing 3 
mol % of folate shows a very high concentration of 157Gd internalized by the cells indicating 
that folate conjugated liposomes are more preferably taken up by the FR+ IGROV-1 cells (50).  
         Targeted and non-targeted liposomes were injected into tumor bearing mice for MRI 
imaging.  MRI scans of the tumor bearing mice were conducted in order to identify the tumor 
and determine the T1 baseline value using a 4.7 T magnet.  Post injection the mice were then 
imaged at 2, 16, and 24 hrs and the weighted T1 images for each respective time point was 
determined.  From Observation of (figure 9.2) it is clear that there is an increase in The MRI 
signal after 2 hour post injection and that specific targeting of the tumor cells by folate liposomes 
has occurred.  MRI imaging of tumors that have been exposed to folate targeted and non-targeted 
liposomes can be seen in (figure 9.3) where it is also observed that there is an increase in signal 
intensity after 2 hour post injection of folate targeted liposomes [24].  After MRI imagining was 
completed liver and kidney sections from tumor bearing mice were analyzed by fluorescence 
microscopy imaging to determine if the folate targeted and non-targeted liposomes have 
infiltrated healthy liver and kidney tissues.  From the microscopy images of the liver and kidneys 
there is low fluorescence intensity indicating that the liposomes have not infiltrated the healthy 
cells in these specific organs and that long systematic circulation is occurring due to the 
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pegylation of the liposomes resulting in accumulation within FR+ IGROV-1 cells of the tumor 
bearing mice [24].    
  
 Figure 9 Schematic picture of Folate-targeted liposome [24]. 
 
       
Figure 9.1 ICP-AES analysis of the cellular uptake of 157Gd after 5 hour incubation period [24]. 
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Figure 9.2 Mouse tumor enhancement using folate targeted and non-targeted liposomes. (a) T1 
measurement at 4.7 T. (b) signal enhancement determined from the mean tumor T1 values for 
pre- and post-liposomal injection [24]. 
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Figure 9.3 MRI images of tumor earing Balb/C nude mice: top images indicate mice injected 
with folate targeted liposomes at 2, 16, and 24 hours; bottom images are of tumor bearing mice 
injected with nontargeted liposomes at 2, 16, and 24 hours [24]. 
 
 
Liposome encapsulated ZnTPP 
      Photodynamic therapy is a light based therapy and has been used in the treatment of many 
conditions including certain cancers. Photodynamic therapy depends on the photosensitization of 
a photosensitizer which can be locally applied or injected into a specific area. The 
photosensitizer once exposed to a certain wavelength of light initiates the production of ¹O2 
(singlet oxygen) from normal oxygen within the tissue.  Singlet oxygen is the main ROS reactive 
oxygen species thought to be the cause of cell death as a result of photo induction [22].   The 
main objective with photodynamic therapy is to cause cytotoxic cell death by the activation of 
¹O2 and at the same time minimize destruction of healthy normal tissue that leads to unwanted 
side effects.   
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       Garcia Diaz et el. were able to design a nano-conjugates consisting of ZnTPP entrapped in 
liposomes in a molar ratio of 100:1 lipid/porphyrin and then tethered to folic acid in order to 
compare the cellular uptake and photocytotoxicity by FR+ HeLa cells and FR- A549 cells. 
Liposomes were prepared by microemulsification process and consisted of non-targeted 
liposomes POPC/OOPS with a molar ratio of 90:10 and folate targeted liposomes 
POPC/OOPS/FA-PEG-DSPE with a molar ratio of 90:10:0.01.  With 85% cell survival for both 
folate targeted and non-targeted liposomes a concentration of 10µM ZnTPP was used as an 
adequate concentration for the delivery to both cell lines [22].  In this study Garcia et el. was able 
to determine that encapsulation efficacy of the photosensitizer was close to 90% and that the PS 
was not affected by the incorporation of the folic acid (See table 10).  They also tested for 
liposome stability to assure that none of the entrapped poryphrin is released from liposomes 
interacting with other proteins or with one another.   
Table 1. Stability of folate targeted and non-targeted liposome measured by lipid and 
photosensitizer content [22]. 
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       Folate receptor positive HeLa cells and Folate negative A549 cells were incubated for 24 
hours with folate targeted and non-targeted liposomes containing ZnTPP photosensitizer then 
lysed and analyzed by fluorescence spectroscopy to determine the uptake of liposomes and PS by 
the cells.  By clear observation of (Figure 10) there is a difference in the uptake of PS by HeLa 
cells and A549 cells. Comparing the fluorescence intensity of the cell lysates for both HeLa, and 
A549 cells incubated with both non-targeted, and folate targeted liposomes it is clear that the 
HeLa cells which are folate receptor positive have a much stronger fluorescence intensity then 
the folate receptor negative cells indicating that the cellular uptake of the liposomes with 
entrapped ZnTPP has occurred [22]. 
        To test for photodynamic toxicity, the uptake of folate targeted liposomes, and non-targeted 
liposomes photosensitization experiments were carried out on HeLa, cells (See figure 10.1) that 
were incubated for a 24 hour period in both liposomes formulations.   HeLa cells were exposed 
to three different concentrations of ZnTPP encased in liposomes then irradiated with green LED 
light.  As observed from (Figure 10.1A) there is a decrease in the number of viable HeLa cells 
that have been exposed to different concentrations of the poryphrin as well as light but HeLa 
cells that were incubated with folate targeted liposomes (Figure 10.1B) indicate that there is a 
higher increase in toxicity indicating that cell cytotoxicity is dependent on concentration as well 
as photodynamic response [22].  Garcia et el. also used photodynamic toxicity to compare the 
folate targeting efficiency of both cell lines with a concentration of 1µM ZnTPP throughout and 
irradiated with 10 Jcm².   Analysis of both HeLa and A549 cells (See figure 10.2) indicates that 
the HeLa cells which are folate receptor positive cells show a higher percent in cell death then 
A549 cells which remained at the same percent whether incubated with folate-targeted or non-
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targeted liposomes.  This data clearly indicates that there is a significant difference in the uptake 
and increase in toxicity of the nano-conjugates and is dependent on folate receptor binding [22].     
 
Figure 10. Cellular uptake of ZnTPP encapsulated in Folate targeted liposomes ( ) and 
nontargeted liposome ( ) by (A) HeLa cells and (B) A549 cells in folate depleted DMEM [22]. 
         
 
 Figure 10.1 Concentration and irradiation time dependence of phototoxicity of ZnTPP 
encapsulated in (A) non-targeted liposomes and (B) Folate- targeted liposomes By HeLa cells. 
Concentrations are ( ) 0.1µM, ( ) 1µM, and ( ) 10 µM [22].  
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Figure 10.2 Photodynamic cytotoxicity using 1µM ZnTPP encapsulated in liposomes with light 
intensity set to 10 Jcm² (A) non-targeted liposomes and (B) Folate-targeted liposomes. p < 0.001 
[22]. 
 
 
 
 
 
 
 
 
 
 
 
  
39 
 
Conclusion 
         Discovery of the folate receptor on the membrane surface of many cancers and the use of 
folic acid conjugated to nanoparticles as a moiety for the delivery of therapeutic and imaging 
agents has been a great achievement in the fight against cancer, and other diseases. The cellular 
uptake, toxicity affects, and bio-imaging capabilities for real time tracking of the nano-
conjugates as well as site specific imaging of the cancer such as MRI for a variety of 
nanoparticles conjugated to folic acid has been reviewed. Folic acid conjugated nanoparticles 
show promising results in the fight against cancer in that there is a better understanding in the 
functionalities of the nanoparticles. In designing and formulating folate nanoparticles to increase 
the efficiency in targeting cancer cells pH environments within the cells were considered. The 
Attachment of ligands on the surface of multifunctional nanoparticles was also implemented and 
researched to provide better systematic circulation and delivery of a large payload via the nano-
conjugate. As time progresses researchers are developing newer and more advanced methods for 
manipulating folate nanoparticle nano-conjugates leading to a more efficient targeting system for 
bio-imaging and destruction of the cancer without causing cell death to surrounding healthy 
tissue.     
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